CD8A and neoplasm: Evidence from experimental studies observed that the infiltration levels of CD8+T increased in YTHDF1-deficient mouse tumour, thereby enhancing an elevated antigen-specific CD8+T cell antitumor response in vivo (Han et al., 2019).